CLINICAL CASE OF PNEUMONIA CAUSED BY POLYRESISTANT KLEBSIELLA PNEUMONIAE
Abstract
One of the global problems of humankind in the 21st century is the growth of antibiotic resistance. In this regard, in 2015, the World Health Organization adopted the resolution, which identifies the global consensus on the growth of antibiotic resistance, which poses a serious threat to human health. The Government of the Russian Federation is also taking measures that determine the State policy to prevent and limit the spread of antimicrobial resistance on the territory of the Russian Federation.
The problem of resistance to antibacterial drugs is most relevant for nosocomial infections (NI), among them the most common pathogens are representatives of the order Enterobacterales (Klebsiella pneumoniae and Escherichia coli), their share in the structure of NI is 50%. The highest clinical significance is the high prevalence of enterobacteria resistance to cephalosporins and carbapenems.
This clinical case demonstrates an example of the development of pneumonia caused by polyresistant Klebsiella pneumonia with fatal outcome.
About the Authors
G. V. AsadullinaRussian Federation
E. G. Mutalova
Russian Federation
G. Ya. Kamaltdinova
Russian Federation
A. E. Nigmatullina
Russian Federation
Z. Ya. Rustyamova
Russian Federation
S. A. Frid
Russian Federation
F. S. Musina
Russian Federation
L. I. Samigullina
Russian Federation
V. R. Galyautdinova
Russian Federation
R. I. Sadikova
Russian Federation
References
1. Beloborodov V.B., Gusarov V.G., Dekhnich A.V. [et al.] Guidelines. “Diagnostics and antimicrobial therapy of the infections caused by multiresistant microorganisms”. Messenger of Anesthesiology and Resuscitation, 2020, Vol. 17, 1: 52-83. (In Russ.) doi: 10.21292/2078-5658-2020-17-1-52-83
2. Beloborodov V. B., Goloschapov O. V., Gusarov V. G. [et al.] Guidelines “Diagnostics and antimicrobial therapy of the infections caused by multiresistant microorganisms" (update 2022). Messenger of Anesthesiology and Resuscitation, 2022, Vol. 19, 2: 84-114. (In Russ.) doi: 10.21292/2078-5658-2022-19-2-84-114
3. Vsemirnaya organizatsiya zdravookhraneniya. Shest'desyat vos'maya sessiya Vsemirnoi assamblei zdravookhraneniya Zheneva, 18-26 maya 2015 g. Rezolyutsii i resheniya (The World Health Organization. Sixty-eighth World Health Assembly Geneva, May 18-26, 2015 Resolutions and decisions). (In Russ.). [Electronic resourse] URL: https://apps.who.int/gb/ebwha/pdf_files/WHA68-REC1/A68_2015_REC1-ru.pdf
4. Rasporyazhenie Pravitel'stva RF ot 30.03.2019 g. № 604-r «O realizatsii Strategii preduprezhdeniya rasprostraneniya antimikrobnoi rezistentnosti v Rossii na period do 2030 g.» (Decree of the Government of the Russian Federation dated 30.03.2019 No. 604-r "On the implementation of the Strategy for preventing the spread of antimicrobial resistance in Russia for the period up to 2030") (In Russ.). URL: http://publication.pravo.gov.ru/Document/View/0001201904090021
5. Programma SKAT (Strategiya Kontrolya Antimikrobnoi Terapii) pri okazanii statsionarnoi meditsinskoi pomoshchi. Rossiiskie klinicheskie rekomendatsii. (The SCAT program (Antimicrobial Therapy Control Strategy) in the provision of inpatient medical care. Russian clinical guidelines) (In Russ.) // https://microbius.ru/library/programma-skat-strategiya-kontrolya-antimikrobnoy-terapii-pri-okazaniistatsionarnoy-meditsinskoy-pomoschi-rossiyskie-klinicheskie-rekomendatsii
6. Sukhorukova M.V., Edelstein M.V.1, Ivanchik N.V [et al.] Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”, Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia, 2019; 21, 2: 147-159. (In Russ.) doi: 10.36488
7. Efimenko T.A., Terekhova L.P., Efremenkova O.V. Current State the Problem of Antibiotic Resistance of Pathogens. Antibiotics and Chemotherapy. 2019;64(5-6):64-68. (In Russ.) doi: 10.24411/0235-2990-2019-100033
8. Yakovlev S.V., Suvorova M.P., Bykov A.O. Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization. Antibiotics and Chemotherapy. 2020;65(5-6):41-69. (In Russ.) doi: 10.37489/0235-2990-2020-65-5-6-41-69
Review
For citations:
Asadullina G.V., Mutalova E.G., Kamaltdinova G.Ya., Nigmatullina A.E., Rustyamova Z.Ya., Frid S.A., Musina F.S., Samigullina L.I., Galyautdinova V.R., Sadikova R.I. CLINICAL CASE OF PNEUMONIA CAUSED BY POLYRESISTANT KLEBSIELLA PNEUMONIAE. Bashkortostan Medical Journal. 2024;19(3):70-74. (In Russ.)